Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia
Recruiting · NCT06643130 · Interventional (participants receive a specific treatment) · Lead sponsor: JW Pharmaceutical
View the official record on ClinicalTrials.gov →Interventions studied
C2402JW0104+C2402JW0104+C2403
What this trial is about
A Multi-center, Randomized, Double-blind, Parallel, Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients with Hypertension and Dyslipidemia
Who can take part
Age range
19 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 3
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Patients with hypertension and dyslipidemia
Exclusion criteria
- The subject not meet the specified msBP and LDL-C level
Where it is running
1 location listed.
- Gangdong Sacred Heart Hospital - Seoul, South Korea